The conversion of glutamine to glutamate by GLS is crucial for the survival of MYC/MYCL overexpressing SCLC cells and we propose that the glutaminolysis pathway is a potential target for this subgroup of SCLCs. This evidence concerns the gene GLS and small cell lung carcinoma.